Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India

In clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause of SS is growth hormone deficiency (GHD). The lack of reliable data on the prevalence of GHD in India limits e...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathew John, Ekaterina Koledova, Kanakatte Mylariah Prasanna Kumar, Harshal Chaudhari
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/2967578
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552593765695488
author Mathew John
Ekaterina Koledova
Kanakatte Mylariah Prasanna Kumar
Harshal Chaudhari
author_facet Mathew John
Ekaterina Koledova
Kanakatte Mylariah Prasanna Kumar
Harshal Chaudhari
author_sort Mathew John
collection DOAJ
description In clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause of SS is growth hormone deficiency (GHD). The lack of reliable data on the prevalence of GHD in India limits estimation of the magnitude of this problem. The diagnosis and treatment of GHD are hurdled with various challenges, restricting the availability of growth hormone (GH) therapy to only a very limited segment of the children in India. This review will firstly summarize the gaps and challenges in diagnosis and treatment of GHD based on literature analysis. Subsequently, it presents suggestions from the members at advisory board meetings to overcome these challenges. The advisory board suggested that early initiation of the therapy could better the chances of achieving final adult height within the normal range for the population. Education and awareness about growth disorders among parents, regular training for physicians, and more emphasis on using the Indian growth charts for growth monitoring would help improve the diagnosis and treatment of children with GHD. Availability of an easy-to-use therapy delivery system could also be beneficial in improving adherence and achieving satisfactory outcomes.
format Article
id doaj-art-c86af2ab3cf04793bf6b211152a9bd6c
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-c86af2ab3cf04793bf6b211152a9bd6c2025-02-03T05:58:20ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/29675782967578Challenges in the Diagnosis and Management of Growth Hormone Deficiency in IndiaMathew John0Ekaterina Koledova1Kanakatte Mylariah Prasanna Kumar2Harshal Chaudhari3Providence Endocrine and Diabetes Specialty Centre, Thiruvananthapuram, Kerala, IndiaLead Endocrinology, Global Medical, Safety and CMO, Merck, Darmstadt, GermanyCentre for Diabetes and Endocrine Care, Bangalore, Karnataka, IndiaBiopharma, NDD and Endocrinology, Merck Specialties Pvt. Ltd., Mumbai, IndiaIn clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause of SS is growth hormone deficiency (GHD). The lack of reliable data on the prevalence of GHD in India limits estimation of the magnitude of this problem. The diagnosis and treatment of GHD are hurdled with various challenges, restricting the availability of growth hormone (GH) therapy to only a very limited segment of the children in India. This review will firstly summarize the gaps and challenges in diagnosis and treatment of GHD based on literature analysis. Subsequently, it presents suggestions from the members at advisory board meetings to overcome these challenges. The advisory board suggested that early initiation of the therapy could better the chances of achieving final adult height within the normal range for the population. Education and awareness about growth disorders among parents, regular training for physicians, and more emphasis on using the Indian growth charts for growth monitoring would help improve the diagnosis and treatment of children with GHD. Availability of an easy-to-use therapy delivery system could also be beneficial in improving adherence and achieving satisfactory outcomes.http://dx.doi.org/10.1155/2016/2967578
spellingShingle Mathew John
Ekaterina Koledova
Kanakatte Mylariah Prasanna Kumar
Harshal Chaudhari
Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
International Journal of Endocrinology
title Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
title_full Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
title_fullStr Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
title_full_unstemmed Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
title_short Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
title_sort challenges in the diagnosis and management of growth hormone deficiency in india
url http://dx.doi.org/10.1155/2016/2967578
work_keys_str_mv AT mathewjohn challengesinthediagnosisandmanagementofgrowthhormonedeficiencyinindia
AT ekaterinakoledova challengesinthediagnosisandmanagementofgrowthhormonedeficiencyinindia
AT kanakattemylariahprasannakumar challengesinthediagnosisandmanagementofgrowthhormonedeficiencyinindia
AT harshalchaudhari challengesinthediagnosisandmanagementofgrowthhormonedeficiencyinindia